103 related articles for article (PubMed ID: 11054718)
21. Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma.
Imura J; Ichikawa K; Takeda J; Fujimori T
Int J Mol Med; 2001 Oct; 8(4):353-8. PubMed ID: 11562771
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
Zhou YN; Li M
Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
[TBL] [Abstract][Full Text] [Related]
23. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.
Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S
Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
[TBL] [Abstract][Full Text] [Related]
25. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
26. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
Yang JF; Chen SL; Liu ZH; Zhang Y
Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma.
Hasegawa T; Yokoyama R; Matsuno Y; Shimoda T; Hirohashi S
Hum Pathol; 2001 Mar; 32(3):257-63. PubMed ID: 11274633
[TBL] [Abstract][Full Text] [Related]
28. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
29. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
30. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
32. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
33. alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Yokomakura N; Ishigami S; Aikou T
J Surg Oncol; 2007 Feb; 95(2):148-55. PubMed ID: 17262732
[TBL] [Abstract][Full Text] [Related]
34. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
35. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.
Saito T; Oda Y; Yamamoto H; Kawaguchi K; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2006 Jun; 37(6):689-97. PubMed ID: 16733209
[TBL] [Abstract][Full Text] [Related]
36. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR
J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
[TBL] [Abstract][Full Text] [Related]
37. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
Fujioka T; Takebayashi Y; Kihana T; Kusanagi Y; Hamada K; Ochi H; Uchida T; Fukumoto M; Ito M
Oncol Rep; 2001; 8(2):249-55. PubMed ID: 11182035
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma.
Nair KS; Naidoo R; Chetty R
Hum Pathol; 2006 Feb; 37(2):125-34. PubMed ID: 16426911
[TBL] [Abstract][Full Text] [Related]
39. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K
Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
